Vivos Therapeutics (VVOS) Enterprise Value (2019 - 2026)
Vivos Therapeutics (VVOS) reported Enterprise Value of -$2.2 million for Q1 2026, up 4.82% year-over-year from -$2.1 million in Q1 2025, and down 6.7% on a QoQ basis from -$2.1 million in Q4 2025.
Vivos Therapeutics (VVOS) has 8 years of Enterprise Value data on file, last reported at -$2.2 million in Q1 2026.
- Quarterly Enterprise Value rose 4.82% year-over-year to -$2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 million (up 4.82% YoY) and the FY2025 annual result came in at -$2.1 million, up 66.63% from the prior year.
- Enterprise Value declined to -$2.2 million in Q1 2026 per VVOS's latest filing, from -$2.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.0 million in Q3 2023 and bottomed at -$17.8 million in Q1 2022.
- The 5-year median for Enterprise Value is -$3.9 million (2023), against an average of -$5.3 million.
- The widest annual swing landed in 2022, when Enterprise Value jumped 85.34%; it then tumbled 531.1% in 2024.
- Tracing VVOS's Enterprise Value over 5 years: stood at -$3.5 million in 2022, then surged by 53.31% to -$1.6 million in 2023, then tumbled by 281.01% to -$6.3 million in 2024, then surged by 66.63% to -$2.1 million in 2025, then declined by 6.7% to -$2.2 million in 2026.
- Per Business Quant, the three latest VVOS Enterprise Value figures stand at -$2.2 million (Q1 2026), -$2.1 million (Q4 2025), and -$3.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -8.17 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -3.09 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -1.12 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -426.00 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | -2.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.23 Mn |
| Dec 31, 2025 | -2.09 Mn |
| Sep 30, 2025 | -3.10 Mn |
| Jun 30, 2025 | -4.40 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Dec 31, 2024 | -6.26 Mn |
| Sep 30, 2024 | -6.31 Mn |
| Jun 30, 2024 | -6.90 Mn |
| Mar 31, 2024 | -2.61 Mn |
| Dec 31, 2023 | -1.64 Mn |
| Sep 30, 2023 | -1.00 Mn |
| Jun 30, 2023 | -3.94 Mn |
| Mar 31, 2023 | -7.05 Mn |
| Dec 31, 2022 | -3.52 Mn |
| Sep 30, 2022 | -6.70 Mn |
| Jun 30, 2022 | -12.66 Mn |
| Mar 31, 2022 | -17.83 Mn |
| Dec 31, 2021 | -24.00 Mn |
| Sep 30, 2021 | -28.50 Mn |
| Jun 30, 2021 | -34.20 Mn |
| Mar 31, 2021 | -14.10 Mn |
| Dec 31, 2020 | -18.21 Mn |
| Dec 31, 2019 | -469,353.00 |